The agonist-stimulated guanosine 5'-(gamma-[S-35]thio)triphosphate binding
assay was used to anatomically localize receptor-activated G-proteins by au
toradiography in post mortem human brain. The optimal conditions for guanos
ine 5'-(gamma-S-35]thio)triphosphate binding to human brain sections were e
stablished in post mortem samples of the prefrontal cortex, hippocampus, ba
sal ganglia, brainstem and cerebellar cortex. An excess of GDP (2 mM) was r
equired to decrease basal activity and obtain effective stimulation by spec
ific agonists. guanosine 5'-(gamma-[S-35]Thio)triphosphate binding was incr
eased after stimulation with specific agonists of different G-protein-coupl
ed receptors. They include cannabinoid (WIN55212-2), mu-opioid ([D-Ala(2)N-
MePh4,Gly(5)-ol]enkephalin), serotonin-1A [(+/-)-8-hydroxy-2-(di-n-propylam
ino)tetralin and serotonin-1B/1D (sumatriptan), cholinergic muscarinic rece
ptors (carbachol) and alpha(2)-adrenoceptors (UK14304). Such stimulation re
ached 1458%, 440%, 188%, 219%, 61% and 339%, respectively, over the basal l
evels. In tissue sections, the use of the above-mentioned agonists (10(-4)
M) showed patterns of anatomical distribution similar to those already desc
ribed by receptor autoradiography, with high densities over the hippocampus
(serotonin-1A receptors), cortex (alpha(2)-adrenoceptors) and striatum (mu
-opioid receptors). The highest binding levels were reached with the cannab
inoid receptor agonist in most of the analysed brain regions. Carbachol pro
duced only moderate stimulation of those same regions. The blockage of agon
ist-stimulated guanosine 5'-(mu-[S-35]thio)triphosphate binding by selectiv
e antagonists verified that the effect was receptor mediated.
This technique provides a method to identify modifications of the receptor-
mediated activation of G-proteins in post mortem human brain with anatomica
l resolution. It also provides valuable information on the level of drug ef
ficacy in the human species. (C) 2000 IBRO. Published by Elsevier Science L
td.